WA
EBACW

Whitebox Advisors’s European Biotech Acquisition Corp. Warrant EBACW Stock Holding History

Whitebox Advisors’s Portfolio EBACW Stock Details EBACW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-16,833
Closed -$5.02K – 733
2022
Q4 		$5.02K Hold
16,833
– – ﹤0.01% 554
2022
Q3 		$2K Hold
16,833
– – ﹤0.01% 868
2022
Q2 		$3K Hold
16,833
– – ﹤0.01% 841
2022
Q1 		$3K Hold
16,833
– – ﹤0.01% 937
2021
Q4 		$10K Buy
+16,833
New +$10.8K ﹤0.01% 805

Whitebox Advisors's EBACW Position: Q1 2023 in Review

Whitebox Advisors sold out of European Biotech Acquisition Corp. Warrant (EBACW) in Q1 2023, closing a stake of 16,833 shares — an estimated $5.02K sold.

Whitebox Advisors first reported a position in EBACW in Q4 2021 and held it in 5 quarters. The position peaked at $10K in Q4 2021. 0 funds tracked by Wall St. Rank hold EBACW as of Q1 2023.

  • Whitebox Advisors reported no remaining European Biotech Acquisition Corp. Warrant position as of Q1 2023 after selling out during the quarter.
  • Whitebox Advisors sold 16,833 European Biotech Acquisition Corp. Warrant shares in Q1 2023, an estimated $5.02K.
  • Whitebox Advisors first reported a position in European Biotech Acquisition Corp. Warrant in Q4 2021 and held it in 5 quarters.
  • Whitebox Advisors's European Biotech Acquisition Corp. Warrant position peaked at $10K in Q4 2021.
  • 0 funds tracked by Wall St. Rank held European Biotech Acquisition Corp. Warrant as of Q1 2023.

Based on Whitebox Advisors's 13F filing for Q1 2023, filed 15 May 2023.